Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Broadcom
AVGO
|
$872M |
| 2 |
Microsoft
MSFT
|
$324M |
| 3 |
Intuit
INTU
|
$313M |
| 4 |
PTC
PTC
|
$289M |
| 5 |
Amazon
AMZN
|
$286M |
Top Sells
| 1 |
Linde
LIN
|
$575M |
| 2 |
Booking.com
BKNG
|
$570M |
| 3 |
Meta Platforms (Facebook)
META
|
$538M |
| 4 |
NVIDIA
NVDA
|
$455M |
| 5 |
Salesforce
CRM
|
$401M |
Sector Composition
| 1 | Technology | 32.54% |
| 2 | Healthcare | 19.02% |
| 3 | Financials | 11.15% |
| 4 | Consumer Discretionary | 10.66% |
| 5 | Communication Services | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Teva Pharmaceuticals
TEVA
$21.7B
| $91.7M | 0.05% |
6,078,241
-659,384
| -10% | -$9.94M |
|
277
SPX Corp
SPXC
$9.3B
| $90.9M | 0.05% |
702,199
-21,509
| -3% | -$2.78M |
|
278
Rhythm Pharmaceuticals
RYTM
$6.85B
| $90.7M | 0.05% |
1,655,350
+435,796
| +36% | +$23.9M |
|
279
Alight
ALIT
$1.99B
| $89.6M | 0.05% |
15,133,986
-2,490,586
| -14% | -$14.7M |
|
280
Neurocrine Biosciences
NBIX
$14.3B
| $88.7M | 0.05% |
783,966
-10,152
| -1% | -$1.15M |
|
281
Saia
SAIA
$8.35B
| $88.3M | 0.05% |
245,957
+35,810
| +17% | +$12.9M |
|
282
Roper Technologies
ROP
$55.8B
| $87.1M | 0.05% |
149,546
+35,667
| +31% | +$20.8M |
|
|
CNTA
283
Centessa Pharmaceuticals
CNTA
$2.12B
| $86.4M | 0.05% |
5,922,486
+1,012,999
| +21% | +$14.8M |
|
284
Structure Therapeutics
GPCR
$1.26B
| $86.1M | 0.05% |
4,355,194
+195,306
| +5% | +$3.86M |
|
285
CACI
CACI
$10.4B
| $85.5M | 0.05% |
228,916
+32,532
| +17% | +$12.1M |
|
286
AST SpaceMobile
ASTS
$11.4B
| $84.4M | 0.05% |
3,509,630
-126,081
| -3% | -$3.03M |
|
287
Doximity
DOCS
$12.9B
| $84.2M | 0.05% |
1,439,531
-702,947
| -33% | -$41.1M |
|
288
iShares Core International Aggregate Bond Fund
IAGG
$10.9B
| $82.5M | 0.05% |
1,650,687
+531,979
| +48% | +$26.6M |
|
289
nVent Electric
NVT
$14.9B
| $81.9M | 0.04% |
1,548,882
+265,445
| +21% | +$14M |
|
290
Gilead Sciences
GILD
$143B
| $81.4M | 0.04% |
728,417
-567,660
| -44% | -$63.5M |
|
|
MTSR
291
Metsera, Inc. Common Stock
MTSR
$3.75B
| $81.3M | 0.04% |
+2,905,462
| New | +$81.3M |
|
292
Universal Display
OLED
$6.91B
| $80M | 0.04% |
550,925
-748
| -0.1% | -$109K |
|
293
CBRE Group
CBRE
$48.9B
| $79.9M | 0.04% |
617,415
+71,226
| +13% | +$9.22M |
|
294
Silgan Holdings
SLGN
$4.84B
| $79.7M | 0.04% |
1,570,866
+55,284
| +4% | +$2.8M |
|
295
Bank of America
BAC
$368B
| $79.5M | 0.04% |
1,926,712
+203,682
| +12% | +$8.4M |
|
296
FirstService
FSV
$9.21B
| $79.4M | 0.04% |
478,046
+361,517
| +310% | +$60M |
|
297
Sotera Health
SHC
$4.42B
| $78.9M | 0.04% |
6,703,110
-1,079,452
| -14% | -$12.7M |
|
298
Donaldson
DCI
$9.44B
| $78.8M | 0.04% |
1,174,326
-122,903
| -9% | -$8.24M |
|
299
Liberty Media Series A
FWONA
$22.6B
| $77.3M | 0.04% |
962,241
+13,334
| +1% | +$1.07M |
|
300
Stantec
STN
$12.3B
| $77.2M | 0.04% |
932,630
+223,524
| +32% | +$18.5M |
|